Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Treatment Strategy for Adolescent Depression
NCT03222570Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Feb 2018
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in major depressive disorder (MDD) (2 arms), sponsored by University of Minnesota. Primary endpoint: Children's Depression Rating Scale - Revised at 16 weeks. Started Feb 2018; status: completed.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03222570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03222570.